TAWNYA L. BOWLES portrait
  • Adjunct Assistant Professor, Surgery

Research Keywords

  • Melanoma and Cutaneous Oncology
  • Melanoma Risk Factors
  • Melanoma, Amelanotic
  • Lentigo Maligna Melanoma
  • Melanoma Surgery
  • Sentinel Node Biopsy for Melanoma and Breast Cancer
  • Assessment of Quality of Cancer Care
  • Health Care Quality, Access, and Evaluation

Presentations

  • Melanoma—Screening and management, 2011 Annual Update in Medicine and Primary Care, Intermountain Medical Center, Salt Lake City, Utah. , , 2011.
  • Controversies in surgery regarding melanoma, Society of Utah Medical Oncologists Fall Meeting, Park City, Utah. , , 2011.
  • “Correlation of radiologic and pathologic findings in invasive lobular breast cancer”, 2nd Annual Academic Surgical Congress, Phoenix, Arizona. , , 2007.
  • “Arginine deprivation therapy as a novel treatment for prostate cancer”, 92nd Annual American College of Surgeons Clinical Congress, Chicago, Illinois. , , 2006.
  • “Arginine deprivation therapy as a novel treatment for pancreatic cancer”, 1st Annual Academic Surgical Congress, San Diego, California. , , 2006.
  • “Arginine deprivation therapy in pancreatic and prostate cancer”, UC Davis 11th Annual Cancer Center Research Symposium, Sacramento, California. , , 2005.
  • “Transcriptional regulation of the proapoptotic protein Bak in pancreatic cancer”, UC Davis Department of Surgery, Resident Research Day, Sacramento, California. , , 2005.
  • Presenter, American Medical Student Association, American River College, Sacramento, CA. , , 2004.

Languages

  • English, Fluent.

Publications

  • Gonzalez CD, Hawkes JE, Bowles TL (date unknown). Malignant melanoma scrotal metastasis: The importance of the genital examination. (pp. 10-12). Vol. 3. Accepted, .
  • Gonzalez CD, Hawkes JE, Bowles TL (date unknown). Recurrent cutaneous angiosarcoma of the ear masquerading as atypical fibroxanthoma. (pp. 445-447). Vol. 2. Accepted, .
  • Gardner LJ, Ward M, Andtbacka RHI, Boucher KM, Bowen GM, Bowles TL, Cohen AL, Grossmann K, Hitchcock YJ, Holmen SL, Hyngstrom J, Khong H, McMahon M, Monroe MM, Ross CB, Suneja G, Wada D, Grossman D (date unknown). Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis. Vol. 27, 477-484. Accepted, .
  • Ray A, Williams MA, Meek SM, Bowen RC, Grossmann KF, Andtbacka RH, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Bowen GM, Holmen SL, VanBrocklin MW, Suneja G, Khong HT (date unknown). A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma. Vol. 7, 64390-64399. Accepted, .
  • Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA (date unknown). Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011). Vol. 79, 238-244. Accepted, .
  • Jones MS, Jones PC, Stern SL, Elashoff D, Hoon DSB, Thompson J, Mozzillo N, Nieweg OE, Noyes D, Hoekstra HJ, Zager JS, Roses DF, Testori A, Coventry BJ, Smithers MB, Andtbacka R, Agnese D, Schultz E, Hsueh EC, Kelley M, Schneebaum S, Jacobs L, Bowles T, Kashani-Sabet M, Johnson D, Faries MB (date unknown). The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma. Vol. 24, 2089-2094. Accepted, .
  • Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM (date unknown). Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. Accepted, .
  • Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM (date unknown). Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. Vol. 376, 2211-2222. Accepted, .
  • Thompson JF, Haydu LE, Uren RF, Andtbacka RH, Zager JS, Beitsch PD, Agnese DM, Mozzillo N, Testori A, Bowles TL, Hoekstra HJ, Kelley MC, Sussman J, Schneebaum S, Smithers BM, McKinnon G, Hsueh E, Jacobs L, Schultz E, Reintgen D, Kane JM, Friedman EB, Wang H, Van Kreuningen L, Schiller V, Elashoff DA, Elashoff R, Cochran AJ, Stern S, Faries MB, MSLT-II Trial Group. (date unknown). Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial. Accepted, .
  • Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ (date unknown). An individualized conditional survival calculator for patients with rectal cancer. Vol. 56, 551-9. Accepted, .
  • Truong A, Hyngstrom JR, Andtbacka RHI, Noyes RD, Wright M, Snyder J, Winters A, Sause WT, Grossmann KF, Khong HT, Bowen GM, Hitchcock YJ, Grossman D, Bowles TL (date unknown). Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status. Vol. 30, 173-178. Accepted, .
  • Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W 3rd, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK (date unknown). Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Vol. 4, 13-37. Accepted, .
  • Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC (date unknown). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp. Vol. 70, 435-42. Accepted, .
  • Swords DS, Andtbacka RHI, Bowles TL, Hyngstrom JR (date unknown). Routine retrieval of pelvic sentinel lymph nodes for melanoma rarely adds prognostic information or alters management. Vol. 29, 38-46. Accepted, .
  • Andtbacka RH, Donaldson MR, Bowles TL, Bowen GM, Grossmann K, Khong H, Grossman D, Anker C, Florell SR, Bowen A, Duffy KL, Leachman SA, Noyes RD (date unknown). Sentinel lymph node biopsy for melanoma in pregnant women. Vol. 20, 689-96. Accepted, .
  • Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Meyskens FL Jr, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB (date unknown). Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Vol. 125, 18-44. Accepted, .
  • Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D (date unknown). Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ. (pp. 835-8). Vol. 71. Accepted, .